| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | John P. Hamill | SrVP/CFO/Prin Fin & Acct Ofcr | Jan 30, 2026 | Buy | $0.89 | 5,700 | 5,073 | 33,433 | Feb 02, 2026, 04:05 PM | |
| APRE | Aprea Therapeutics, Inc. | John P. Hamill | SrVP/CFO/Prin Fin & Acct Ofcr | Dec 10, 2025 | Buy | $1.16 | 5,000 | 5,825 | 27,733 | Dec 11, 2025, 08:31 AM | |
| APRE | Aprea Therapeutics, Inc. | John P. Hamill | SrVP/CFO/Prin Fin & Acct Ofcr | Oct 11, 2024 | Buy | $2.46 | 50 | 123 | 19,368 | Oct 16, 2024, 08:30 AM | |
| APRE | Aprea Therapeutics, Inc. | John P. Hamill | SrVP/CFO/Prin Fin & Acct Ofcr | Oct 10, 2024 | Buy | $2.61 | 450 | 1,174 | 19,318 | Oct 15, 2024, 08:30 AM | |
| APRE | Aprea Therapeutics, Inc. | John P. Hamill | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 13, 2024 | Buy | $7.29 | 1,010 | 7,363 | 15,503 | Mar 14, 2024, 08:54 PM | |
| APRE | Aprea Therapeutics, Inc. | John P. Hamill | SrVP/CFO/Prin Fin & Acct Ofcr | Feb 27, 2023 | Award/Grant | $5.25 | 1,000 | 5,250 | 14,493 | Feb 27, 2023, 06:37 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More